Skip to content

Clinical trials

Phase 3 Parkinson Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Country / region: United States Clear all

120 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20026
20035
20049
20057
20065
200712
20084
20097
20104
20112
20122
20135
20147
20157
20163
20173
20183
20198
20204
20212
20222
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed90
Terminated17
Unknown status6
Active, not recruiting3
Recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie10
UCB Pharma9
Impax Laboratories, LLC7
Solvay Pharmaceuticals6
Adamas Pharmaceuticals, Inc.5
GlaxoSmithKline4
Kyowa Kirin, Inc.4
Acorda Therapeutics3
Pfizer3
Teva Branded Pharmaceutical Products R&D, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease120
Dyskinesias19
Parkinsonian Disorders12
Brain Diseases4
Central Nervous System Diseases4
Dizziness4
Movement Disorders4
Nervous System Diseases4
Neurodegenerative Diseases4
Pure Autonomic Failure4

Trials

Showing 1 to 25 of 120. Each trial links to its page on Pharma Observatory.

20 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.